TY - JOUR
T1 - Usefulness of Incorporating Hypochloremia into the Get With The Guidelines–Heart Failure Risk Model in Patients With Acute Heart Failure
AU - Misumi, Kayo
AU - Matsue, Yuya
AU - Nogi, Kazutaka
AU - Sunayama, Tsutomu
AU - Dotare, Taishi
AU - Maeda, Daichi
AU - Kagiyama, Nobuyuki
AU - Kasai, Takatoshi
AU - Kitai, Takeshi
AU - Oishi, Shogo
AU - Akiyama, Eiichi
AU - Suzuki, Satoshi
AU - Yamamoto, Masayoshi
AU - Kida, Keisuke
AU - Okumura, Takahiko
AU - Nogi, Maki
AU - Ishihara, Satomi
AU - Ueda, Tomoya
AU - Kawakami, Rika
AU - Saito, Yoshihiko
AU - Minamino, Tohru
N1 - Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Although hypochloremia is strongly associated with adverse prognosis in acute heart failure (AHF), it is unknown whether incorporating hypochloremia into the preexisting risk model improves the model performance. We calculated the Get With The Guidelines–Heart Failure (GWTG-HF) risk score in 1,428 patients with AHF (derivation cohort) and developed 2 risk scores incorporating brain natriuretic peptide (BNP) into the GWTG-HF risk score (GWTG-BNP risk score) and incorporating both BNP and hypochloremia (GWTG-BNP-Cl risk score). Hypochloremia was defined as <98 mmol/L. The external validation and comparison of model performance were performed in an independent group of 1,256 patients with AHF (validation cohort). All models were tested for in-hospital mortality. Hypochloremia was observed in 9.4% and 12.2% of the derivation and validation cohorts, respectively. Hypochloremia was an independent predictor of in-hospital mortality in the derivation cohort (odds ratio 2.02; p = 0.028). In the validation cohort, the GWTG-HF, GWTG-BNP, and GWTG-BNP-Cl risk scores demonstrated good discrimination (area under the curve: 0.742, 0.749, and 0.763, respectively). However, the GWTG-BNP-Cl risk score was more reliable than the GWTG-HF and GWTG-BNP risk scores in risk reclassification (net reclassification improvement: 0.491 and 0.408, respectively; p <0.01 for both). Moreover, this score demonstrated a good calibration of the GWTG-BNP-Cl model (Hosmer-Lemeshow test: p = 0.479). In conclusion, incorporating hypochloremia into the preexisting risk model improves the model performance.
AB - Although hypochloremia is strongly associated with adverse prognosis in acute heart failure (AHF), it is unknown whether incorporating hypochloremia into the preexisting risk model improves the model performance. We calculated the Get With The Guidelines–Heart Failure (GWTG-HF) risk score in 1,428 patients with AHF (derivation cohort) and developed 2 risk scores incorporating brain natriuretic peptide (BNP) into the GWTG-HF risk score (GWTG-BNP risk score) and incorporating both BNP and hypochloremia (GWTG-BNP-Cl risk score). Hypochloremia was defined as <98 mmol/L. The external validation and comparison of model performance were performed in an independent group of 1,256 patients with AHF (validation cohort). All models were tested for in-hospital mortality. Hypochloremia was observed in 9.4% and 12.2% of the derivation and validation cohorts, respectively. Hypochloremia was an independent predictor of in-hospital mortality in the derivation cohort (odds ratio 2.02; p = 0.028). In the validation cohort, the GWTG-HF, GWTG-BNP, and GWTG-BNP-Cl risk scores demonstrated good discrimination (area under the curve: 0.742, 0.749, and 0.763, respectively). However, the GWTG-BNP-Cl risk score was more reliable than the GWTG-HF and GWTG-BNP risk scores in risk reclassification (net reclassification improvement: 0.491 and 0.408, respectively; p <0.01 for both). Moreover, this score demonstrated a good calibration of the GWTG-BNP-Cl model (Hosmer-Lemeshow test: p = 0.479). In conclusion, incorporating hypochloremia into the preexisting risk model improves the model performance.
UR - https://www.scopus.com/pages/publications/85118862303
UR - https://www.scopus.com/pages/publications/85118862303#tab=citedBy
U2 - 10.1016/j.amjcard.2021.09.020
DO - 10.1016/j.amjcard.2021.09.020
M3 - Article
C2 - 34763832
AN - SCOPUS:85118862303
SN - 0002-9149
VL - 162
SP - 122
EP - 128
JO - American Journal of Cardiology
JF - American Journal of Cardiology
ER -